Developing stem cell-based therapies to treat our most serious diseases
From his landmark research on the mechanisms of developmental biology to his pivotal role in the launch of ISCRM, Dr. Randall T. Moon has made a lasting impact on science and on thousands of students, colleagues, and collaborators in labs around the world. At the heart of it all is a natural instinct to make room for serendipity. Read More
For those who know Eileen and Larry Tietze, it isn’t surprising that they are among the very earliest supporters of the Institute for Stem Cell and Regenerative Medicine (ISCRM), as well as some of the most impactful. Investing in the potential of ideas and in the promise of people is the hallmark of their philanthropy. Read More
There are currently no treatments that prevent or slow the progression of this memory-robbing affliction. Researchers at the UW Medicine Institute for Stem Cell and Regenerative Medicine are determined to change that by taking a closer look at the factors that cause Alzheimer’s. Read More
Two years ago, a major investment from Gree Real Estate jump started an ambitious effort to transform health on a global scale. The challenge: to engineer the earliest stages of human heart development. Now, three teams of ISCRM researchers and trainees, known together as The Gree Group, are making exciting progress. Read More
Under the billing of Tall Orders, Dr. Murry raised the curtain on the profound potential of stem cells to change the way humans confront chronic disease. Watch the TEDxSeattle program here or read more about the landmark heart regeneration research underway at UW Medicine. Read More
A new article in Science details exciting advancements in 3D organ printing, the result of an ongoing collaboration between ISCRM faculty member Kelly Stevens and researchers at Rice University. More on the paper, which was co-first-authored by PhD student Daniel Corbett, can be found here.
